endopredict test (Myriad Genetics)
90
Structured Review
Myriad Genetics
endopredict test
Endopredict Test, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm36831644-204-0-4
Average 90 stars, based on 1 article reviews
Endopredict Test, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm36831644-204-0-4
Average 90 stars, based on 1 article reviews
endopredict test - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing. Article Snippet: Purpose Genomic tests improve accuracy of risk prediction for early breast cancers but these are expensive.. This study evaluated the clinical utility of EndoPredict®, in terms of impact on adjuvant therapy recommendations and identification of parameters to guide selective application.. Methods Patients with ER-positive, HER2-negative, and early-stage invasive breast cancer were tested with EndoPredict®. Article Title: Classic and New Markers in Diagnostics and Classification of Breast Cancer Article Snippet: The Article Title: Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer. Article Snippet: Article Title: Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity Article Snippet: The Adjuvant:Article Title: Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries Article Snippet: .. In a separate study that focused on adjuvant systemic therapy for breast carcinoma, treatment decisions were changed for 4 of 11 patients after the MDT reviewed WfO’s recommendations and |
